(NYSE: ACH) Accendra Health's forecast annual revenue growth rate of 1.47% is not forecast to beat the US Medical Distribution industry's average forecast revenue growth rate of 7.08%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 13.69%.
Accendra Health's revenue in 2026 is $2,715,928,000.On average, 7 Wall Street analysts forecast ACH's revenue for 2026 to be $199,117,625,200, with the lowest ACH revenue forecast at $190,233,915,768, and the highest ACH revenue forecast at $210,222,261,990. On average, 7 Wall Street analysts forecast ACH's revenue for 2027 to be $207,082,330,208, with the lowest ACH revenue forecast at $192,761,177,934, and the highest ACH revenue forecast at $227,070,676,430.
In 2028, ACH is forecast to generate $217,804,048,488 in revenue, with the lowest revenue forecast at $197,356,200,054 and the highest revenue forecast at $241,315,245,002.